{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:21:10Z","timestamp":1769948470220,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.kint.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T09:18:53Z","timestamp":1527758333000},"page":"346-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution\u2013induced fibrosis"],"prefix":"10.1016","volume":"94","author":[{"given":"Anne-Catherine","family":"Raby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe T.","family":"Gonz\u00e1lez-Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aled","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Topley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"L\u00f3pez-Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario O.","family":"Lab\u00e9ta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.03.014_bib1","doi-asserted-by":"crossref","first-page":"909373","DOI":"10.1155\/2014\/909373","article-title":"Clinical causes of inflammation in peritoneal dialysis patients","volume":"2014","author":"Cho","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","article-title":"Interleukin-6 signaling drives fibrosis in unresolved inflammation","volume":"40","author":"Fielding","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.03.014_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1681\/ASN.2015080923","article-title":"Toll-Like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis","volume":"28","author":"Raby","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib4","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1681\/ASN.2006121417","article-title":"Peritoneal changes after exposure to sterile solutions by catheter","volume":"18","author":"Flessner","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10157-011-0533-y","article-title":"Mechanisms and interventions in peritoneal fibrosis","volume":"16","author":"Tomino","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib6","doi-asserted-by":"crossref","first-page":"3543678","DOI":"10.1155\/2016\/3543678","article-title":"Molecular mechanisms underlying peritoneal EMT and fibrosis","volume":"2016","author":"Strippoli","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.kint.2018.03.014_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib9","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1093\/ndt\/gfr217","article-title":"Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors","volume":"26","author":"Colmont","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.03.014_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1315","article-title":"Regulation of lung injury and repair by Toll-like receptors and hyaluronan","volume":"11","author":"Jiang","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.03.014_bib12","doi-asserted-by":"crossref","first-page":"484167","DOI":"10.1155\/2012\/484167","article-title":"Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells","volume":"2012","author":"Yung","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.kint.2018.03.014_bib13","doi-asserted-by":"crossref","first-page":"44941","DOI":"10.1038\/srep44941","article-title":"Genomic reprograming analysis of the mesothelial to mesenchymal transition identifies biomarkers in peritoneal dialysis patients","volume":"7","author":"Ruiz-Carpio","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.03.014_bib14","doi-asserted-by":"crossref","first-page":"e51243","DOI":"10.1371\/journal.pone.0051243","article-title":"A\u00a0critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors","volume":"8","author":"Peroval","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.kint.2018.03.014_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.192.6.769","article-title":"Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking","volume":"192","author":"Mummert","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.03.014_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4049\/jimmunol.0802909","article-title":"Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering","volume":"183","author":"Raby","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib18","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.4049\/jimmunol.171.12.6680","article-title":"Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk","volume":"171","author":"LeBouder","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib19","doi-asserted-by":"crossref","first-page":"185ra164","DOI":"10.1126\/scitranslmed.3005544","article-title":"Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens","volume":"5","author":"Raby","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2018.03.014_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/089686080902900218","article-title":"Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: structural and functional alterations of the peritoneal membrane","volume":"29","author":"Gonzalez-Mateo","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.03.014_bib21","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-beta1 protects the peritoneal membrane from dialysate-induced damage","volume":"22","author":"Loureiro","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib22","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1681\/ASN.2015080909","article-title":"Immune-regulatory molecule CD69 controls peritoneal fibrosis","volume":"27","author":"Liappas","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/089686080302300205","article-title":"Inhibition of caspases improves bacterial clearance in experimental peritonitis","volume":"23","author":"Catalan","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.03.014_bib24","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.167.11.6217","article-title":"Fas ligand engagement of resident peritoneal macrophages in\u00a0vivo induces apoptosis and the production of neutrophil chemotactic factors","volume":"167","author":"Hohlbaum","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.03.014_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.kint.2018.03.014_bib26","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1590\/S1807-59322011001200023","article-title":"Protective measures against ultrafiltration failure in peritoneal dialysis patients","volume":"66","author":"Aguirre","year":"2011","journal-title":"Clinics"},{"key":"10.1016\/j.kint.2018.03.014_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","article-title":"Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","volume":"92","author":"Aufricht","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.03.014_bib28","unstructured":"Mahmood U, Cho Y, Johnson DW. Peritoneal dialysis solutions. In: Ekart R, ed. Some Special Problems in Peritoneal Dialysis. IntechOpen Web site. Available at: https:\/\/www.intechopen.com\/books\/some-special-problems-in-peritoneal-dialysis\/peritoneal-dialysis-solutions. Accessed May 9, 2018."},{"key":"10.1016\/j.kint.2018.03.014_bib29","first-page":"CD010050","article-title":"Glutamine supplementation for critically ill adults","author":"Tao","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2018.03.014_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ndt\/gfr459","article-title":"Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids","volume":"27","author":"Kratochwill","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.03.014_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis","volume":"89","author":"Ferrantelli","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.03.014_bib32","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00467-016-3461-y","article-title":"Is there such a thing as biocompatible peritoneal dialysis fluid?","volume":"32","author":"Schmitt","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib33","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib34","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ajpath.2010.12.034","article-title":"Interleukin-1 receptor-mediated inflammation impairs the heat shock response of human mesothelial cells","volume":"178","author":"Kratochwill","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2018.03.014_bib35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1111\/j.1523-1755.2004.66040.x","article-title":"Overexpression of HSP-72 confers cytoprotection in experimental peritoneal dialysis","volume":"66","author":"Bidmon","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.03.014_bib36","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1152\/ajprenal.00503.2005","article-title":"Evidence for HSP-mediated cytoskeletal stabilization in mesothelial cells during acute experimental peritoneal dialysis","volume":"292","author":"Endemann","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.03.014_bib37","unstructured":"Leung JCK, Chan LYY, Lai KN, Tang SCW. Inflammation in peritoneal dialysis. In: Peralta AA, ed. The Latest in Peritoneal Dialysis. IntechOpen Web site. Available at: https:\/\/www.intechopen.com\/books\/the-latest-in-peritoneal-dialysis\/inflammation-in-peritoneal-dialysis. Accessed May 9, 2018."},{"key":"10.1016\/j.kint.2018.03.014_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/089686080502500514","article-title":"Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells","volume":"25","author":"Kyuden","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.03.014_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/089686080102100221","article-title":"Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?","volume":"21","author":"Duman","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.03.014_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1681\/ASN.V133721","article-title":"Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats","volume":"13","author":"Margetts","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib41","first-page":"CD009120","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2018.03.014_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ckj\/sfu140","article-title":"Strategies for preserving residual renal function in peritoneal dialysis patients","volume":"8","author":"Nongnuch","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2018.03.014_bib43","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor beta in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.03.014_bib44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-beta","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.kint.2018.03.014_bib45","doi-asserted-by":"crossref","first-page":"e0132336","DOI":"10.1371\/journal.pone.0132336","article-title":"Therapeutic effects of treatment with anti-TLR2 and anti-TLR4 monoclonal antibodies in polymicrobial sepsis","volume":"10","author":"Lima","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.kint.2018.03.014_bib46","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1681\/ASN.2013040332","article-title":"Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients","volume":"24","author":"Lin","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.03.014_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.0.CO;2-G","article-title":"Soluble CD14 acts as a negative regulator of human T cell activation and function","volume":"29","author":"Rey Nores","year":"1999","journal-title":"Eur J Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818302540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818302540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:50:24Z","timestamp":1758761424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818302540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0085253818302540"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.03.014","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution\u2013induced fibrosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}